Lei Xu

8PUBLICATIONS
29CO-AUTHORS
Sensory systemsMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NanomedicineNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 27, 2026
Deciphering and Targeting the Schwannoma-Neuron-Macrophage Crosstalk for the Treatment of Schwannomatosis and Associated Pain.

Zhenzhen Yin, Limeng Wu, Yanling Zhang

|Feb 11, 2026
NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing loss.

Simeng Lu, Zhenzhen Yin, Limeng Wu

|Jan 28, 2026
Advancements in Preclinical Models for NF2-Related Schwannomatosis Research.

Bo-Shi Zhang, Simeng Lu, Scott R Plotkin

|Oct 05, 2024
Losartan rewires the tumor-immune microenvironment and suppresses IGF-1 to overcome resistance to chemo-immunotherapy in ovarian cancer.

Yao Sun, Zhenzhen Yin, Shuang Li

|Jul 15, 2021
Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models.

Limeng Wu, Sasa Vasilijic, Yao Sun

|May 12, 2021
Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas.

Zohreh Amoozgar, Jonas Kloepper, Jun Ren

Pageof 2

Frequent Collaborators

3 joint publications

Rakesh K Jain

2 joint publications

Lukas D Landegger

2 joint publications

Jun Ren

2 joint publications

Peigen Huang